TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 273 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,099,267 | +20.4% | 71,058 | +22.3% | 0.13% | +23.5% |
| Q2 2023 | $912,987 | -8.9% | 58,115 | -4.5% | 0.10% | -14.3% |
| Q1 2023 | $1,002,709 | +6.4% | 60,844 | +0.8% | 0.12% | -4.8% |
| Q4 2022 | $941,959 | +14.5% | 60,382 | -4.9% | 0.12% | +4.2% |
| Q3 2022 | $823,000 | +50.7% | 63,479 | +63.1% | 0.12% | +57.9% |
| Q2 2022 | $546,000 | +38.6% | 38,919 | +41.5% | 0.08% | +58.3% |
| Q1 2022 | $394,000 | +10.1% | 27,504 | +25.9% | 0.05% | -5.9% |
| Q3 2021 | $358,000 | +0.8% | 21,842 | +3.6% | 0.05% | -3.8% |
| Q2 2021 | $355,000 | +86.8% | 21,074 | +103.1% | 0.05% | +3.9% |
| Q1 2021 | $190,000 | +15.2% | 10,378 | +14.4% | 0.05% | +15.9% |
| Q4 2020 | $165,000 | – | 9,072 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
| GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
| Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
| BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
| Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
| Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
| Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
| DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
| TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |